Acadia (ACHC) Should Be Bought on CMA Enforcement Order Weakness - Mizuho
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Acadia Healthcare (ACHC) PT, Estimates Cut at Jefferies
February 17, 2016 6:51 AM ESTJefferies analyst Brian Tanquilut lowered his price target on Acadia Healthcare (NASDAQ: ACHC) to $85.00 (from $100.00) but maintained a Buy rating.
Tanquilut commented, "Our thesis on ACHC (strong organic growth boosted by M&A, with optionality for Medicaid-driven upside) was further validated by... More
Acadia Healthcare (ACHC) Reports In-Line Q4 EPS, Offers Q1 & FY Guidance
February 16, 2016 4:14 PM ESTAcadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $495.3 million versus the consensus estimate of $488 million.
GUIDANCE:
Acadia Healthcare sees Q1 2016 EPS of $0.53-$0.54, versus the consensus of... More
